Lexicon Pharmaceuticals, Inc.

LXRX

$1.80

Name : Lexicon Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $798,695,872.00

EPSttm : -0.14

Lexicon Pharmaceuticals, Inc.

$1.80

3.49%

$0.065

LXRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.15

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.02

EPS Last/This Y

-0.03

EPS This/Next Y

-0.02

Price

1.79

Target Price

3.86

Analyst Recom

1.8

Performance Q

-29.61

Upside

-208.9%

Beta

1.07

Ticker: LXRX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	LXRX	2.29	0.05	0.06	31824
2026-08-31	LXRX	2.26	0.05	0.29	31856
2026-09-01	LXRX	2.19	0.04854719957928	0.035714285714286	31901
2026-09-02	LXRX	2.24	0.05	0.27	31931
2026-09-03	LXRX	2.26	0.05	0.73	32005
2026-09-04	LXRX	2.23	0.05	2.21	32041
2026-09-08	LXRX	2.22	0.05	0.01	32060
2026-09-09	LXRX	2.14	0.05	0.60	32234
2026-09-10	LXRX	2.02	0.05	0.65	32287
2026-09-11	LXRX	1.99	0.05	1.19	32366
2026-09-14	LXRX	1.98	0.06	0.04	32597
2026-09-15	LXRX	2.02	0.05	0.03	32593
2026-09-16	LXRX	2.03	0.06	0.17	32732
2026-09-17	LXRX	2.03	0.05	0.71	32800
2026-09-18	LXRX	2.05	0.05	0.04	32750
2026-09-21	LXRX	2.04	0.05	0.08	29871
2026-09-22	LXRX	2.17	0.05	0.16	29929
2026-09-23	LXRX	2.06	0.05	0.22	29961
2026-09-24	LXRX	1.86	0.05	0.21	30035
2026-09-25	LXRX	1.79	0.05	1.35	30080
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	LXRX	2.29	-32.2	-9.2	-0.17
2026-08-31	LXRX	2.25	-32.2	-9.2	-0.17
2026-09-01	LXRX	2.18	-32.2	-7.9	-0.17
2026-09-02	LXRX	2.25	-32.2	-36.2	-0.17
2026-09-03	LXRX	2.26	-32.2	-33.8	-0.17
2026-09-04	LXRX	2.24	-32.2	-32.3	-0.17
2026-09-08	LXRX	2.22	-32.2	-32.3	-0.17
2026-09-09	LXRX	2.14	-32.2	-29.0	-0.17
2026-09-10	LXRX	2.02	-32.2	-26.7	-0.17
2026-09-11	LXRX	1.99	-32.2	-32.0	-0.17
2026-09-14	LXRX	1.97	-32.2	-31.7	-0.17
2026-09-15	LXRX	2.02	-32.2	-35.0	-0.17
2026-09-16	LXRX	2.02	-32.2	-35.0	-0.17
2026-09-17	LXRX	2.03	-32.2	-33.3	-0.17
2026-09-18	LXRX	2.05	-32.2	-33.7	-0.17
2026-09-21	LXRX	2.04	-32.2	-32.5	-0.17
2026-09-22	LXRX	2.17	-32.2	-39.3	-0.17
2026-09-23	LXRX	2.06	-32.2	-27.7	-0.17
2026-09-24	LXRX	1.85	-32.2	-23.0	-0.17
2026-09-25	LXRX	1.79	-32.2	-29.4	-0.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	LXRX	0.00	5.10	14.98
2026-08-31	LXRX	0.00	5.11	14.98
2026-09-01	LXRX	0.00	5.11	14.98
2026-09-02	LXRX	0.00	5.11	14.98
2026-09-03	LXRX	0.00	5.11	14.98
2026-09-04	LXRX	0.00	5.11	14.98
2026-09-08	LXRX	0.00	5.16	14.98
2026-09-09	LXRX	0.00	5.16	14.98
2026-09-10	LXRX	0.00	5.16	14.98
2026-09-11	LXRX	0.00	5.16	13.49
2026-09-14	LXRX	0.00	5.17	13.47
2026-09-15	LXRX	0.00	5.17	13.47
2026-09-16	LXRX	0.00	5.17	13.47
2026-09-17	LXRX	0.00	5.17	13.47
2026-09-18	LXRX	0.00	5.17	13.47
2026-09-21	LXRX	0.00	5.17	13.47
2026-09-23	LXRX	0.00	5.17	13.47
2026-09-24	LXRX	0.00	5.17	13.47
2026-09-25	LXRX	0.00	5.17	13.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

-0.04

Insider Transactions

Institutional Transactions

5.17

Beta

1.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

71.6

Max Drawdown 5-Year %

-95.2

Target Price

3.86

P/E

Forward P/E

PEG

P/S

19.26

P/B

4.58

P/Free Cash Flow

EPS

-0.15

Average EPS Est. Cur. Y

-0.17

EPS Next Y. (Est.)

-0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-147.38

Relative Volume

0.86

Return on Equity vs Sector %

-61.3

Return on Equity vs Industry %

-41.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-29.4

◆ LXRX Healthcare

$1.79

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

21/25

Volume

7/15

Valuation

12/20

TP/AR

3/10

Options

7/10

RSI

30.5

Range 1M

0.9%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

3/30

Estimates

3/20

Inst/Vol

6/15

Options

5/10

EPS Yr

-18.4%

EPS NY

-23.3%

52W%

44%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +115.6% upside

Quality

6/30

Valuation

15/30

Growth

1/25

Stability

6/10

LT Trend

3/5

Upside

+115.6%

Quality

LXRX — P/E HistoricalBiotechnology

Lexicon Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 81

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

LXRX

Latest News

—

Caricamento notizie per LXRX…

stock quote shares LXRX – Lexicon Pharmaceuticals Inc. Stock Price stock today

news today LXRX – Lexicon Pharmaceuticals Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch LXRX – Lexicon Pharmaceuticals Inc. yahoo finance google finance

stock history LXRX – Lexicon Pharmaceuticals Inc. invest stock market

stock prices LXRX premarket after hours

ticker LXRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: LXRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y